SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061521
Filing Date
2023-11-09
Accepted
2023-11-09 07:10:27
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20230930.htm   iXBRL 10-Q 2805921
2 EX-31.1 rptx-ex31_1.htm EX-31.1 17963
3 EX-31.2 rptx-ex31_2.htm EX-31.2 17730
4 EX-32.1 rptx-ex32_1.htm EX-32.1 9004
5 EX-32.2 rptx-ex32_2.htm EX-32.2 9134
  Complete submission text file 0000950170-23-061521.txt   9698186

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rptx-20230930_def.xml EX-101.DEF 152547
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20230930.xsd EX-101.SCH 47768
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20230930_pre.xml EX-101.PRE 305240
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20230930_lab.xml EX-101.LAB 400262
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rptx-20230930_cal.xml EX-101.CAL 41291
59 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20230930_htm.xml XML 2081737
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 231390027
SIC: 2834 Pharmaceutical Preparations